James Carroll presented evidence to Congress on the effectiveness of PBM for treating pain as an alternative to opioids. Prof. Praveen Arany explained how and why PBM works, and Annette Quinn RN gave her first hand experience in treating over 854 patients with Oral Mucositis.

The briefing was a historic step for PBM, moving the conversation forward as members of congress were shown stories by members of the public on how PBM had impacted them and enabled them to live a life free from opioids.

The panel outlined the needs for PBM adoption as:

Research grants to fund further basic science experiments, therapeutic dose, and large multi-center clinical trials.

FDA to create a PBM specific product code.

Public and private health insurance reimbursement.

Briefing Materials

The opioid crisis and how Photobiomodulation Therapy might helpBy James Carroll

Stay informed of latest news on STEM Education, innovation, science, and technology. Our newsletter aggregates the latest news, commentary, breaking reports, and videos from around the web and deliver them to your inbox.